SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-21-012508
Filing Date
2021-05-21
Accepted
2021-05-21 16:05:19
Documents
6
Period of Report
2021-05-21

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 641905
2 logo_001.jpg GRAPHIC 2392
3 sig_001.jpg GRAPHIC 5272
4 formdef14a_001.jpg GRAPHIC 151029
5 formdef14a_002.jpg GRAPHIC 202851
6 formdef14a_003.jpg GRAPHIC 115434
  Complete submission text file 0001493152-21-012508.txt   1300413
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37648 | Film No.: 21948975
SIC: 2835 In Vitro & In Vivo Diagnostic Substances